Is Trending Stock Gilead Sciences, Inc. (GILD) a Buy Now? - Yahoo Finance
5 days ago • Google News
Gilead Sciences Inc (GILD)
US$ 98.38-3.01%
Price Chart
Key Statistics
Market Cap
$ 132.06B
P/E Ratio
22.30
Revenue (TTM)
$ 28.74B
Volume
9.92M
52W High
$ 119.12
52W Low
$ 59.82
Dividend Yield
2.98%
Beta
0.28
Technicals
50-Day MA
106.2504
200-Day MA
93.9935
52 Week High
119.1239
52 Week Low
59.8241
About GILD
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
Employees
17600
Headquarters
Foster City, CA
CEO
Mr. Daniel P. O'Day
Latest News
Unusual Options Alert: The Smart Money Is Piling Into Gilead Sciences (GILD) - Barchart.com
20 hours ago • Google News
Watch These 4th & 5th Graders Crush Billy Strings’ “Gild The Lily” - Live For Live Music
6 days ago • Google News
Environment, Social and Governance (ESG) Risk Ratings
Total ESG Risk Score
22.15
Percentile: 30.98
Environmental Risk Score
0.53
Percentile: 2
Social Risk Score
12.97
Percentile: 2
Governance Risk Score
7.65
Percentile: 2
Controversy Level
ESG data provided by Sustainalytics, Inc.
GILD
Category Average
2Moderate Controversy Level
NoneSevere
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg